Ledger.Open graph →
SEC Form D · filed July 13, 2011

REATA PHARMACEUTICALS INC

Offering
$300.0M
Sold
$300.0M
Exemption
Industry
Biotechnology
Location
IRVING, TX
Type

People & firms on this filing (30)

Jack B. Nielsen · Irving, TXDirectorWilliam C. Wigley · Irving, TXExecMelean Visnick · Irving, TXExecDennis Stone · Dallas, TXDirectorEdward W. Rose · Dallas, TXDirectorJ. W. Huff · Southlake, TXExec · DirectorJason D. Wilson · Irving, TXExecColin Meyer · Irving, TXExecKent Mcgaughy · Dallas, TXDirectorMelissa Krauth · Irving, TXExecJohn Walling · Irving, TXExecJames Bass · Dallas, TXDirectorCasi Deyoung · Irving, TXExecJonathan Bell · South San Francisco, CAExec · DirectorLouise Du Putron · South San Francisco, CADirectorGreg Henry · Austin, TXDirectorDoug Sherman · Austin, TXDirectorJeff Grogg · Portland, ORExecMark Haas · Portland, ORExecSelwyn Ellis · Clinton, MSDirectorWirt Yerger · Clinton, MSDirectorIsatou Sey · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsExecGrant E. Lippincott · Omaha, NEExecTyler Bruch · Emmetsburg, IAExecAlan Kluis · Minneapolis, MNExecPaul Audhya · Irving, TXExecRobert M. Kral, Jr · Irving, X1ExecCatherine Fanning · Irving, TXExecCasi Deyoung · Austin, TXExecNancy Wysenski · Irving, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗